Loading people...
Alison Maughan is an Investment Manager at Northern Gritstone based in the United Kingdom. Prior to her current position, she served as an Investment Manager within the life sciences team at Deepbridge Capital, where she managed early-stage venture capital and Enterprise Investment Scheme funding. During her tenure at the firm, she executed transactions across the full deal cycle and worked directly with a portfolio of more than 50 investee companies. Maughan received her foundational academic training at the University of Oxford, where she earned a Bachelor of Arts degree in Biological Sciences before entering the finance sector. She was also recognized with an internal emerging leader award while managing corporate venture capital initiatives at Deepbridge Capital. Her professional background centers entirely on identifying, funding, and scaling early-stage life sciences startups through strategic venture capital investments across the region.
Alison Maughan stands out as a key investor at Deepbridge Capital, a prominent UK venture capital firm renowned for its focus on early-stage and growth-stage companies. In her capacity as an investor, Alison plays a crucial role in Deepbridge's mission to fuel innovation and economic growth by backing promising enterprises across various sectors.
At Deepbridge Capital, Alison Maughan's investment focus primarily revolves around disruptive technology and life sciences. Deepbridge is well-known for managing Enterprise Investment Scheme (EIS) and Seed Enterprise Investment Scheme (SEIS) funds, which provide vital growth capital to innovative UK businesses. Alison's expertise contributes significantly to identifying companies that not only demonstrate strong commercial viability but also align with Deepbridge's commitment to impactful investment. This includes ventures in areas such as biotech, medtech, software as a service (SaaS), and other cutting-edge technological advancements.
Alison's career background is rooted in a deep understanding of financial markets and the venture capital landscape. While specific details of her early career are not widely publicized, her contributions at Deepbridge Capital suggest a robust foundation in investment analysis, strategic planning, and portfolio management. Investors like Alison are instrumental in navigating the complexities of early-stage funding, providing not just capital but also invaluable mentorship and strategic oversight to help nascent companies scale and achieve their full potential. Her work involves rigorous due diligence, market analysis, and a keen eye for identifying the next generation of industry leaders.
While individual notable investments led solely by Alison Maughan are not typically highlighted publicly due to the collaborative nature of venture capital firms, her efforts contribute directly to Deepbridge Capital's impressive portfolio. Deepbridge has a track record of supporting companies that go on to achieve significant milestones, from successful product launches to further funding rounds and strategic exits. Alison's involvement ensures that Deepbridge continues to invest in companies poised for substantial growth and market impact, reinforcing the firm's reputation as a vital partner for innovative businesses. Her strategic insights help shape the investment decisions that drive the success of Deepbridge's diverse portfolio, ultimately fostering innovation within the UK's vibrant startup ecosystem.
Alison Maughan is an investor at Deepbridge Capital, a leading UK venture capital firm. She specializes in identifying and supporting high-growth companies, particularly in the technology and life sciences sectors.
Alison Maughan primarily invests in disruptive technology and life sciences companies. Her focus aligns with Deepbridge Capital's strategy of providing growth capital to innovative UK businesses through EIS and SEIS funds.
Alison Maughan works as an investor at Deepbridge Capital, a prominent UK-based venture capital firm known for its investments in early-stage and growth-stage companies.
